Effect Of Ashwagandha Churna In Diabetic Neuropathy
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2023/09/058073
- Lead Sponsor
- Dr Ayush Dhankhar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients having cardinal symptoms of Madhumeha Upadrava like Daha, Harsha, Suptata and Shula will be selected.
2.Diagnosed case of Type 2 Diabetic Neuropathy will be included.
3.Mild to moderate Neuropathy patients having Toronto score between 6 to 11 will be included.
4.Both fresh and treated cases will be included in the study.
5.On-going oral hypoglycaemic agents will be continued during study.
6.No other neuropathy managing drugs are allowed during study period.
7.Patient who are willing to sign written consent will be included.
1.IDDM (Type 1 DM) will be excluded from study.
2.Diabetic patients with chronic alcoholism will be excluded.
3.Pregnant and lactating women will be excluded.
4.Patient with any other serious condition which have negative impact on the nerves like Meningitis/encephalitis/Polio etc. will be excluded.
5.Patient having any other associated clinical condition like Dementia, Parkinson, Stroke which influence peripheral nerve function will be excluded.
6.Patient having ulceration/infection of feet.
7.Medical/Surgical condition limiting functional mobility.
8.Non ambulatory patients.
9.Patients who are not willing to participate / consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method